Are you familiar with MEK inhibitors and their role in treating neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas (PNs)? Are you up to date with relevant clinical trial data on MEK inhibition in NF1 PNs released within the year? Through this interactive Booster Quiz, test your knowledge, competency, and confidence in the latest data on new and emerging MEK inhibitors for NF1-associated PNs. This unique learning experience provides: instant expert feedback on your answer selections opportunity to see how well you do relative to your peers downloadable summary with key supporting evidence and relevant practice tips.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/accelerating-adoption-latest-clinical-evidence-into-clinical-practice-nf1
- Start Date: 2024-09-11 05:00:00
- End Date: 2024-09-11 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Springworks Therapeutics - Amount: 24875.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest